118 related articles for article (PubMed ID: 6192372)
1. Elevated maternal serum alpha-fetoprotein caused by midtrimester amniocentesis: a prognostic factor.
Thomsen SG; Isager-Sally L; Lange AP; Saurbrey N; Grønvall S; Schiøler V
Obstet Gynecol; 1983 Sep; 62(3):297-300. PubMed ID: 6192372
[TBL] [Abstract][Full Text] [Related]
2. Fetal-maternal bleeding associated with genetic amniocentesis.
Mennuti MT; Brummond W; Crombleholme WR; Schwarz RH; Arvan DA
Obstet Gynecol; 1980 Jan; 55(1):48-54. PubMed ID: 6153239
[TBL] [Abstract][Full Text] [Related]
3. Elevated maternal serum midtrimester alpha-fetoprotein levels are associated with fetoplacental ischemia.
Spong CY; Ghidini A; Walker CN; Ossandon M; Pezzullo JC
Am J Obstet Gynecol; 1997 Nov; 177(5):1085-7. PubMed ID: 9396898
[TBL] [Abstract][Full Text] [Related]
4. Fetomaternal hemorrhage after midtrimester genetic amniocentesis at King Chulalongkorn Memorial Hospital.
Tannirandorn Y; Romayanan O
J Med Assoc Thai; 1999 Nov; 82(11):1089-93. PubMed ID: 10659542
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic use of meternal serum alpha-fetoprotein levels.
Cowchock FS; Jackson LG
Obstet Gynecol; 1976 Jan; 47(1):63-8. PubMed ID: 54892
[TBL] [Abstract][Full Text] [Related]
6. Midtrimester amniocentesis. An analysis of 923 cases with neonatal follow-up.
Cruikshank DP; Varner MW; Cruikshank JE; Grant SS; Donnelly E
Am J Obstet Gynecol; 1983 May; 146(2):204-11. PubMed ID: 6189400
[TBL] [Abstract][Full Text] [Related]
7. Feto-maternal haemorrhage associated with genetic amniocentesis: results of a randomized trial.
Tabor A; Bang J; Nørgaard-Pedersen B
Br J Obstet Gynaecol; 1987 Jun; 94(6):528-34. PubMed ID: 2441735
[TBL] [Abstract][Full Text] [Related]
8. Midtrimester amniocentesis: is it safe? A single centre controlled prospective study of 517 consecutive amniocenteses.
Sant-Cassia LJ; MacPherson MB; Tyack AJ
Br J Obstet Gynaecol; 1984 Aug; 91(8):736-44. PubMed ID: 6380566
[TBL] [Abstract][Full Text] [Related]
9. Amniotic fluid alpha-fetoprotein levels and pregnancy outcome.
Brumfield CG; Cloud GA; Finley SC; Cosper P; Davis RO; Huddleston JF
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 1):822-5. PubMed ID: 2445206
[TBL] [Abstract][Full Text] [Related]
10. Midtrimester screening for open neural tube defects: correlation of sonography with amniocentesis results.
Lindfors KK; McGahan JP; Tennant FP; Hanson FW; Walter JP
AJR Am J Roentgenol; 1987 Jul; 149(1):141-5. PubMed ID: 2438918
[TBL] [Abstract][Full Text] [Related]
11. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes.
Williams MA; Hickok DE; Zingheim RW; Luthy DA; Kimelman J; Nyberg DA; Mahony BS
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1032-7. PubMed ID: 1384333
[TBL] [Abstract][Full Text] [Related]
12. The relation between maternal serum alpha-fetoprotein levels and fetomaternal haemorrhage.
Hay DL; Barrie JU; Davison GB; Buttery BW; Horacek I; Pepperell RJ; Fliegner JR
Br J Obstet Gynaecol; 1979 Jul; 86(7):516-20. PubMed ID: 89863
[TBL] [Abstract][Full Text] [Related]
13. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications.
Waller DK; Lustig LS; Cunningham GC; Feuchtbaum LB; Hook EB
Obstet Gynecol; 1996 Nov; 88(5):816-22. PubMed ID: 8885920
[TBL] [Abstract][Full Text] [Related]
14. Significance of meconium in midtrimester diagnostic amniocentesis.
King CR; Prescott G; Pernoll M
Am J Obstet Gynecol; 1978 Nov; 132(6):667-9. PubMed ID: 82406
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs.
Ashwood ER; Cheng E; Luthy DA
Am J Med Genet; 1987 Mar; 26(3):531-9. PubMed ID: 2436476
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pregnancy outcome after amniocentesis for previous neural tube defect or raised maternal serum alphafetoprotein.
Read AP; Donnai D; Harris R; Donnai P
Br J Obstet Gynaecol; 1980 May; 87(5):372-6. PubMed ID: 6155932
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum alpha-fetoprotein and previous neural tube defects.
Wald N; Barker S; Peto R; Brock DJ; Bonnar J
Br J Obstet Gynaecol; 1976 Mar; 83(3):213-6. PubMed ID: 56196
[TBL] [Abstract][Full Text] [Related]
18. Genetic amniocentesis: significance of intraamniotic bleeding and placental location.
Lenke RR; Ashwood ER; Cyr DR; Gravett M; Smith JR; Stenchever MA
Obstet Gynecol; 1985 Jun; 65(6):798-801. PubMed ID: 2582322
[TBL] [Abstract][Full Text] [Related]
19. Cost-benefit analysis of targeted ultrasonography for prenatal detection of spina bifida in patients with an elevated concentration of second-trimester maternal serum alpha-fetoprotein.
Vintzileos AM; Ananth CV; Fisher AJ; Smulian JC; Day-Salvatore D; Beazoglou T; Knuppel RA
Am J Obstet Gynecol; 1999 May; 180(5):1227-33. PubMed ID: 10329882
[TBL] [Abstract][Full Text] [Related]
20. Circulating intercellular adhesion molecule-1 in amniotic fluid, maternal serum alpha-fetoprotein levels, and intrauterine growth retardation.
Salafia CM; DeVore GR; Mainolfi E; Kelly J; Pezzullo JC; Rothlein R
Am J Obstet Gynecol; 1993 Oct; 169(4):830-4. PubMed ID: 7694462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
